|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||4.65 - 4.99|
|52 Week Range||1.90 - 12.30|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Previously in this series, we discussed the target price upgrades for Canopy Growth (WEED) (CGC) from PI Financial and Canaccord Genuity. In this part, we’ll discuss two more upgrades on August 16.
WKN: A1C4WM) today announced, in connection with the spin-out of its subsidiary Australis Capital Inc. ("Australis"), Australis has received a receipt for its final prospectus dated August 14, 2018 (the "Final Prospectus"). The Final Prospectus was filed with the securities regulatory authorities in all provinces and territories of Canada and is available under Australis' SEDAR profile at www.sedar.com. Receipt of the Final Prospectus will permit Aurora's Board of Directors (the "Board") to set the Record date of the transaction, which the company expects the Board will announce within the coming days. Additionally, Australis received conditional approval to list its shares and warrants on the Canadian Securities Exchange ("CSE"), as well as completed an oversubscribed private placement for proceeds of $17 million.
Project Aims to Study Outcomes of CBD Therapy for Pain Relief TSX: ACB MONTREAL , Aug. 16 , 2018 /CNW/ - Aurora Cannabis Inc. (" Aurora ") (TSX: ACB) (OTCQB: ACBFF) (Frankfurt : 21P; WKN: ...
NEW YORK, NY / ACCESSWIRE / August 16, 2018 / U.S. markets retreated on Wednesday as ongoing trade concerns and the currency crisis in Turkey continued to take center stage. The Dow Jones Industrial Average ...
On August 14, the overall cannabis sector was in the deep red. The Horizons Marijuana Life Sciences ETF (HMMJ) fell 4.5% during the day, while the Emerging Marijuana Growers Index ETF (HMJR) fell 5.7%. The sell-off in the cannabis sector came amid the ongoing global economic concerns, especially in emerging markets. However, the developed markets were broadly positive with the S&P 500 Index (SPY) up by 64 basis points and the TSE Composite Index up by 49 basis points.
Canopy Growth (CGC) (WEED) is well-known when it comes to investing in the cannabis sector. The company reported its earnings for the first quarter of 2019 on August 14. Canopy Growth is one of the largest cannabis producers by capacity. The company has aggressively built its portfolio to serve Canadian recreational cannabis users.
WKN: A1C4WM) and Alcanna Inc. ("Alcanna") (TSX:CLIQ.TO - News) applaud the Ontario Government on its new plans for the responsible sale of recreational cannabis products through government-operated online sales, and the private sector. Aurora and Alcanna have entered into a license agreement which – as soon as regulations permit – will allow Alcanna to open retail cannabis stores under the brand name "Aurora".
WKN: A1C4WM) today announced that its acquisition of Anandia Laboratories Inc. ("Anandia") is now complete. The previously announced arrangement, under the provisions of the Business Corporations Act (British Columbia), means that among other things, Aurora has now acquired all of the issued and outstanding shares of Anandia in an all-share transaction (the "Transaction"). Anandia is a world-leading cannabis-focused science company, specialized in genomics, metabolite profiling, plant breeding, disease characterization, and cultivar certification, as well as providing testing services to producers and patient-cultivators.
Last week, the cannabis sector saw positive movement, and the Horizons Marijuana Life Sciences ETF (HMMJ) ended 1% higher between the closing on August 3 and the closing on August 10. The Emerging Marijuana Growers Index ETF (HMJR) also rose 2.6% over the same period, while the ETFMG Alternative Harvest ETF (MJ) fell by 82 basis points.
WKN: A1C4WM) is pleased to provide the following update on its international operations. The Company has successfully shipped cultivars from its Mountain facility to Denmark to commence populating the Phase I Aurora Nordic facility, a 100,000 square foot, retrofitted hybrid greenhouse, which will be ramping up to full production capacity of 8,000 kg per year of medical cannabis over the coming months. Aurora Nordic is a 51%-Aurora owned subsidiary owned in partnership with Alfred Pederson & Son.
The company’s losses are similar to those of Aphria (APHQF), Supreme Cannabis (SPRWF), and Aurora Cannabis (ACBFF). The current consensus price target for CannTrust was 14.3 Canadian dollars, which declined from 14.5 Canadian dollars a month ago.
TSX: ACB EDMONTON , Aug. 10, 2018 /CNW/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (TSX: ACB) (OTCQB: ACBFF) (Frankfurt : 21P; WKN: A1C4WM) is pleased to announce that Dr. Debra ...
Arguably, the two hottest sectors over the past 12 months have been Cannabis and Fintech stocks HENDERSON, NV / ACCESSWIRE / August 9, 2018 / Huge news keeps coming for both sectors, NYSE parent company ...
CORAL GABLES, FL / ACCESSWIRE / August 8, 2018 / The marijuana market has offered investors a new opportunity for what many are calling "the green rush". A new trend that investors are looking at is one of a mergers and acquisitions approach. Not only has it allowed cannabis businesses to expand a national footprint but also an international footprint mainly with companies in Canada.
Among the well-known cannabis stocks (SEED-TSE) such as Canopy Growth (WEED) and Aurora Cannabis (ACB) (ACBFF), Aphria (APHQF) has been one of the worst performers with a YTD loss of 52%. The consensus ratings on Aphria also remained unchanged from the last month. Out of the eight analysts, three maintained a “strong buy” recommendation on the stock, and four analysts maintained a “buy” on Aphria.
Aurora Cannabis stock (ACB) (ACBFF) has had a terrible performance over the last month. It is easy to see why investors are staying away from the cannabis sector (MJ) including Aphria (APHQF) and Cronos Group (CRON), both of which are down in the double digits YTD. The consensus rating on Aurora Cannabis is unchanged from last month.
Cannabis stocks have experienced significant declines since the beginning of this year. With that said, some big names such as Canopy Growth (WEED), Aurora Cannabis (ACB) (ACBFF), and Aphria (APHQF) have made heavy capital investments and are here to stay. In this series, we’ll discuss what analysts think about marijuana stocks (HMMJ) in terms of their ratings and price target.
WKN: A1C4WM) and Alcanna Inc. ("Alcanna") (TSX:CLIQ.TO - News) today announced the companies have reached a license agreement whereby Alcanna has been given exclusive rights to open retail cannabis stores under the brand name "Aurora" across Canada. Alcanna's position as the biggest private sector liquor retailer in Canada, aligns with Aurora's position as one of the world's leading cannabis companies.
Further Strengthening Aurora's Technologically Advanced Hybrid Greenhouse Operations TSX: ACB EDMONTON , Aug. 7, 2018 /CNW/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (TSX: ...
The overall sentiment towards the cannabis sector remained weak last week. The Horizons Marijuana Life Sciences ETF (HMMJ) ended last week 2% lower, while the Emerging Marijuana Growers Index ETF (HMJR) was down by 1.3%. On the other hand, the ETFMG Alternative Harvest ETF (MJ) gained 1.1% last week.
Five countries -- and five marijuana stocks -- that are important in the expansion of worldwide weed.
HENDERSON, NV / ACCESSWIRE / August 3, 2018 / Polls show almost 90% of Americans are in favor of medicinal marijuana. Smart investors are hopping on bargains in these sectors as they can see the writing on the wall. A small biotech company that we have discovered is BRTX (BioRestorative Therapies, Inc.).
CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, today announced publication of an article covering High Hampton Holdings Corp.’s (HC.CN) (HC.CN) (HC.CN) (0HCN.F) CoachellaGro project, providing investors with a compelling opportunity to capitalize on the state’s massive growth. With permits in place and construction beginning, investors may want to take a closer look at the stock. The Californian cannabis industry is projected to exceed $7.7 billion by 2021, according to Arcview Market Research, making it one of the largest cannabis markets in the world.